Quantitative determination of (-)-2′-deoxy-3′-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection

被引:45
作者
Hoetelmans, RMW
Profijt, M
Meenhorst, PL
Mulder, JW
Beijnen, JH
机构
[1] Slotervaart Hosp, Dept Pharm & Pharmacol, NL-1066 EC Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 713卷 / 02期
关键词
lamivudine; (-)-2 '-deoxy-3 '-thiacytidine;
D O I
10.1016/S0378-4347(98)00218-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance liquid chromatographic method for the quantitative determination of the HIV reverse transcriptase inhibitor lamivudine ((-)-2'-deoxy-3'-thiacytidine, 3TC, Epivir(R)) in human plasma, saliva and cerebrospinal fluid is described. Lamivudine was extracted from samples using silica extraction columns prior to reversed-phase high-performance liquid chromatography with ultraviolet detection at 270 nm. The method has been validated over the range of 10 (lower limit of quantitation) to 5000 ng/ml using a 0.5-ml sample volume. Between-day and within-day precisions ranged from 3.5 to 9.0%. The assay has been used for the quantitative analysis of lamiwdine in plasma and cerebrospinal fluid of HIV-1 infected patients. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 14 条
[11]   DETERMINATION OF 2'-DEOXY-3'-THIACYTIDINE (3TC) IN HUMAN URINE BY LIQUID-CHROMATOGRAPHY - DIRECT-INJECTION WITH COLUMN-SWITCHING [J].
MORRIS, DM ;
SELINGER, K .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (02) :255-264
[12]   A PHASE I/II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
PLUDA, JM ;
COOLEY, TP ;
MONTANER, JSG ;
SHAY, LE ;
REINHALTER, NE ;
WARTHAN, SN ;
RUEDY, J ;
HIRST, HM ;
VICARY, CA ;
QUINN, JB ;
YUEN, GJ ;
WAINBERG, MA ;
RUBIN, M ;
YARCHOAN, R .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (06) :1438-1447
[13]   EVALUATION OF SAFETY AND EFFICACY OF 3TC (LAMIVUDINE) IN PATIENTS WITH ASYMPTOMATIC OR MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I/II STUDY [J].
VANLEEUWEN, R ;
KATLAMA, C ;
KITCHEN, V ;
BOUCHER, CAB ;
TUBIANA, R ;
MCBRIDE, M ;
INGRAND, D ;
WEBER, J ;
HILL, A ;
MCDADE, H ;
DANNER, SA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1166-1171
[14]   THE PRODUCTION AND EVALUATION OF A RADIOLIGAND AND ANTISERUM FOR THE RADIOIMMUNOASSAY OF SUBNANOGRAM PER MILLILITER CONCENTRATIONS OF LAMIVUDINE [J].
WRING, SA ;
ONEILL, RM ;
WILLIAMS, JL ;
JENNER, WN ;
DANIEL, MJ ;
GRAY, MRD ;
NEWMAN, JJ ;
WELLS, GN ;
SUTHERLAND, DR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (12) :1573-1583